At 54 years of age, this female patient faced the daunting diagnosis of Stage 4 breast cancer, with metastasis to the liver and bones, heralding a challenging battle ahead. Despite undergoing breast surgery, chemotherapy, and radiation, a CT scan on August 8, 2012, revealed the persistence of metastasis in the liver and bones, casting a shadow over her health.
在54岁时，这位女性患者面临了第四期乳腺癌的艰巨诊断，肝脏和骨骼的转移进一步加剧了她未来的挑战。尽管接受了乳腺手术、化疗和放疗，但2012年8月8日的CT扫描显示，在肝脏和骨骼仍然存在转移灶，为她的健康蒙上了一层阴影。
However, with unwavering determination and the initiation of ECCT therapy as Treatment to fight Stage 4 Breast Cancer on September 8, 2012, a remarkable transformation unfolded. Despite the aggressive nature of her condition, the patient's general clinical condition remained stable and healthy, a testament to the efficacy of ECCT treatment.
然而，凭借坚定的决心和2012年9月8日ECCT治疗的启动，一场显著的变革正在上演。尽管她的病情进展迅速，但患者的一般临床状况保持稳定和健康，这证明了ECCT治疗的有效性。
Subsequent CT scan results on June 11, 2013, showcased a promising development: a near disappearance of hypoechoic masses, signifying significant progress in combating the spread of cancer. While hyperechoic masses, indicative of dead mass deposits, remained, some showed no change, while others continued to shrink on subsequent CT scans in June 2014.
随后2013年6月11日的CT扫描结果展示了一个令人振奋的进展：低回声肿块几乎消失，标志着对抗癌症扩散取得了显著的进展。虽然一些表示死亡肿块残留，但一些在随后的2014年6月CT扫描中持续缩小。As of the patient's latest assessment on December 9, 2014, her general condition remains healthy, underscoring the enduring efficacy of ECCT therapy in managing Stage 4 breast cancer with metastasis.
截至患者2014年12月9日的最新评估，她的一般情况仍然健康，突显了ECCT治疗在管理伴有转移的第四期乳腺癌方面的持久有效性。
Comments